Concurrent Validity of a Computer-Based Cognitive Screening Tool for Use in Adults with HIV Disease
- 1 June 2011
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 25 (6), 351-357
- https://doi.org/10.1089/apc.2011.0051
Abstract
As the incidence of HIV-associated dementia has decreased, the survival of HIV-infected individuals with milder forms of cognitive impairment has increased. Detecting this milder impairment in its earliest stages has great clinical and research importance. We report here the results of an initial evaluation of the Computer Assessment of Mild Cognitive Impairment (CAMCI®), a computerized screening tool designed to assess abnormal cognitive decline with reduced respondent and test administrator burden. Fifty-nine volunteers (29 HIV infected; age=50.9 years; education=14.9 years; 36/59 males) completed the CAMCI® and a battery of neuropsychological tests. The CAMCI was repeated 12 and 24 weeks later. The results from the CAMCI were compared to Global and Domain Impairment scores derived from the full neuropsychological test battery. The CAMCI detected mild impairment (compared with normal and borderline test performance) with a sensitivity of 0.72, specificity of 0.97, positive predictive rate of 0.93, and a negative predictive rate of 0.89. Median stability over 12 and 24 weeks of follow-up was 0.32 and 0.46, respectively. These rates did not differ as a function of serostatus. A discriminant function analysis correctly classified 90% of the subjects with respect to their overall Global Impairment Rating from six of the CAMCI scores. This preliminary study demonstrates that the CAMCI is sensitive to mild forms of cognitive impairment, and is stable over 24 weeks of follow-up. A larger trial to obtain risk-group appropriate normative data will be necessary to make the instrument useful in both clinical practice and research (e.g., clinical trials).Keywords
This publication has 12 references indexed in Scilit:
- HIV-1 infection and cognitive impairment in the cART era: a reviewAIDS, 2011
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapyNeurology, 2010
- An examination of Alzheimer's disease case definitions using Medicare claims and survey dataAlzheimer's & Dementia, 2010
- Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual menNeurology, 2009
- Computer Assessment of Mild Cognitive ImpairmentPostgraduate Medicine, 2009
- Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapyAnnals of Neurology, 2008
- Updated research nosology for HIV-associated neurocognitive disordersNeurology, 2007
- Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIVJournal of Clinical and Experimental Neuropsychology, 2004
- Incidence and Prevalence of Dementia in the Cardiovascular Health StudyJournal of the American Geriatrics Society, 2004
- Nature and vocational significance of neuropsychological impairment associated with HIV infectionThe Clinical Neuropsychologist, 1996